医学
内科学
心脏病学
肥厚性心肌病
梗阻性肥厚性心肌病
心肌病
人口
心脏病
梅德林
心源性猝死
梗阻性心肌病
心力衰竭
作者
Nicolas Pallet,Céline Narjoz,Marie‐Anne Loriot
摘要
To the Editor: In the Study of Mavacamten in Adolescents with Symptomatic Obstructive Hypertrophic Cardiomyopathy (SCOUT-HCM), conducted by Rossano et al. (July 23 issue), 1 two patients in the mavacamten group had serious adverse cardiac events, including one patient with episodes of syncope that were deemed by the investigator to be related to mavacamten. It would have been helpful to determine the activity of the cytochrome P450 (CYP) enzyme CYP2C19 in that patient. Mavacamten is metabolized by CYP2C19. A person with two nonfunctional alleles, which are represented mostly by the variant alleles CYP2C19*2 (rs4244285) and CYP2C19*3 (rs4986893), is considered to have . . .
科研通智能强力驱动
Strongly Powered by AbleSci AI